As C/EBPδ is lost in many PDAC patients, it would be of great clinical value to not only assess C/EBPδ expression in primary tumor tissues, but also that of C/EBPγ, and especially C/EBPβ, to predict patient survival more accurately. The gene discussed is CEBPG; the disease is neoplasm.